» Articles » PMID: 20081869

Anti-virulence Strategies to Combat Bacteria-mediated Disease

Overview
Specialty Pharmacology
Date 2010 Jan 19
PMID 20081869
Citations 586
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotic resistance is one of the greatest challenges of the twenty-first century. However, the increasing understanding of bacterial pathogenesis and intercellular communication has revealed many potential strategies to develop novel drugs to treat bacteria-mediated disease. Interference with bacterial virulence and/or cell-to-cell signalling pathways is an especially compelling approach, as it is thought to apply less selective pressure for the development of bacterial resistance than traditional strategies, which are aimed at killing bacteria or preventing their growth. Here, we discuss the mechanisms of bacterial virulence and present promising anti-virulence strategies and compounds for the future treatment of bacterial infections.

Citing Articles

Lasso peptides sviceucin and siamycin I exhibit anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant pathogens.

Boudrioua A, Baetz B, Desmadril S, Goulard C, Groo A, Lombard C iScience. 2025; 28(3):111922.

PMID: 40034853 PMC: 11872507. DOI: 10.1016/j.isci.2025.111922.


Emerging antimicrobial therapies for Gram-negative infections in human clinical use.

Hickson S, Ledger E, Wells T NPJ Antimicrob Resist. 2025; 3(1):16.

PMID: 40016340 PMC: 11868545. DOI: 10.1038/s44259-025-00087-2.


A review of gut failure as a cause and consequence of critical illness.

Soranno D, Coopersmith C, Brinkworth J, Factora F, Muntean J, Mythen M Crit Care. 2025; 29(1):91.

PMID: 40011975 PMC: 11866815. DOI: 10.1186/s13054-025-05309-7.


Quercetin and Silybin Decrease Intracellular Replication of in SHK-1 Cell.

Parra M, Izquierdo K, Rubio M, de la Fuente A, Tello M, Modak B Int J Mol Sci. 2025; 26(3).

PMID: 39940952 PMC: 11818823. DOI: 10.3390/ijms26031184.


Purpurin suppresses Salmonella invasion of host cells by reducing the secretion of T3SS-1 effector proteins.

Shi Z, Guo Z, Li S, Jiang C, Wang J, Deng X Sci Rep. 2025; 15(1):4507.

PMID: 39915561 PMC: 11802881. DOI: 10.1038/s41598-025-86822-1.


References
1.
Mitrophanov A, Groisman E . Signal integration in bacterial two-component regulatory systems. Genes Dev. 2008; 22(19):2601-11. PMC: 2751022. DOI: 10.1101/gad.1700308. View

2.
Walters M, Sircili M, Sperandio V . AI-3 synthesis is not dependent on luxS in Escherichia coli. J Bacteriol. 2006; 188(16):5668-81. PMC: 1540066. DOI: 10.1128/JB.00648-06. View

3.
Novick R, Geisinger E . Quorum sensing in staphylococci. Annu Rev Genet. 2008; 42:541-64. DOI: 10.1146/annurev.genet.42.110807.091640. View

4.
Chen Z, Moayeri M, Zhou Y, Leppla S, Emerson S, Sebrell A . Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J Infect Dis. 2006; 193(5):625-33. PMC: 7110013. DOI: 10.1086/500148. View

5.
Lane M, Mobley H . Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 2007; 72(1):19-25. DOI: 10.1038/sj.ki.5002230. View